Small bowel cancer enzyme Nr. 5
About half of the malignant tumors of the small intestine are neuroendocrine tumors (NET), which are less common in other organs of the digestive tract, in the lungs or on the skin.
Gastrointestinal stromal tumors (GIST) make up a good 10 percent of cases in the small intestine.
In 2019, a total of around 3,400 people, 1,700 of them women, contracted small bowel cancer in Germany. In around seven out of ten people, the diagnosis is only made at an advanced stage (UICC III / IV).
Our small intestine cancer enzyme No. 5 specifically helps to slow down the growth and spread of cancer cells in the organism. Cancer cells employ various strategies to avoid being destroyed by the body's immune defenses. For example, they camouflage themselves with a cover made of an endogenous material and can thus migrate to other parts of the body undetected. Our small bowel cancer enzyme number 5 recognizes these camouflaged cells and destroys them. This way, metastases can be effectively prevented. Another deception of the cancer cells is also undermined by our small intestine cancer enzyme No. 5: The cancer cells produce structures that are classified as harmful and attacked by the immune system. Cancer cells that are still alive remain unmolested and have a free path to multiply. Our small bowel cancer enzyme No. 5 is able to split the deceptive structures.
Recommended daily dose: 2 x 1 capsule
